Johnson & Johnson Cuts FY20 Adj. EPS Guidance From $8.95-$9.10 To $7.50-$7.90, Cuts Operational Sales Guidance From $85.8B-$86.6B To $77.5B-$80.5B; Guidance Includes Impact Of Coronavirus And Related Investments
Benzinga Newsdesk